lobbying_activities: 2066160

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2066160	278f76c2-da8b-443d-89ec-fecff3e59833	Q4	KOUNTOUPES DENHAM CARR & REID, LLC	320918	GLENMARK PHARMACEUTICALS, INC., USA	2017	fourth_quarter	PHA	General information about the company and the industry. Issues related to affordability and pricing of pharmaceuticals.	HOUSE OF REPRESENTATIVES,SENATE	50000		0	0	2018-01-17T17:51:11.193000-05:00